HEALTH● LOWJul 10 · Jul 10, 2026, 9:12 PM
Weekly GLP-1 Can Further Reduce Heavy Drinking
Human Progress
“A team of National Institutes of Health (NIH) scientists and international colleagues have reported the first evidence from a randomized controlled clinical trial indicating that a GLP-1 receptor agonist can reduce the days in which patients with obesity and alcohol use disorder engage in heavy drinking. Led by researchers at Copenhagen University Hospital, the new […] The post Weekly GLP-1 Can Further Reduce Heavy Drinking appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoOver 80% Students Discharged, Govt Investigating Cause Of Bilharzia Drug Reactions — Health CommissionerChannels TVHEALTH2h agoMore than a slip: Dangers of falls in old ageVanguard NigeriaHEALTH2h agoHigh temperatures linked to more than 700,000 deaths in 2023, study estimatesThe TelegraphHEALTH2h agoAir quality slips to ‘poor’ category in Delhi, parts of north IndiaThe Hindu